1Nicolini A, Caciagli M, Zampierl F. Usefulness of CEA, TPA, CA242, CA199 in the diagnosis of primary colorectal cancer and at its relapese[J]. Cancer Detect Prev, 1995,19 : 183.
8Yamamo to H, Miyake Y, Noura S, et al. Tumor marker for colo rectal cancer[J].Gan To Kagaku Ryoho,2001,28 : 1 299 - 1 305.
9Gebauer G, Muller RW. Tumor marker concetrations in normal and malignant tissues of colo rectal cancer patients and their prognostic relevance [J]. Anticancer Res, 1997,17 : 2 939 - 2 942.
6Kuusela P, Haglund C, Roberts PJ. Comparision of new tumor marker CA242 with CA19-9, CAS0 and Carcinoembryonic antigen (CEA) digestive tract disease. Br J Cancer, 1991,63(4) :636-640.
7Holmgren J, Lindholm L, Persson B, et al. Detection by monoclonal antibody of carbohydrate antigen CA50 in serum of patients with cacinoma. Br Med J,1984,288(6429) : 1479-1482.
8Rothlin MA,Joller H, Largiader F, et al. CA242 is a new tumor marker for pancreatic cancer. Cancer, 1993,71(3) :701-707.
9Nilsson O, Johansson C, Gimelias B, et al. Sensitivity and Specificity of CA242 in gastrointestinal cancer. A Comparison with CEA, CA50 and CA19-9. Br J Cancer, 1992,65(2) :215-221.
10Guadagni F, Roselli M, Cosimelli M, et al. TAG - 72 ( CA72 - 4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer. 1993,72:2098.
8Tyczynski JE,Bray F,Parkin DM.Lung cancer in Europe in 2000:epidemiology,prevention,and early detection[J].Lancet Oneol,2003,4(1):45.
9von Eggeling F,Davies H,Lomas L,et al.Tissue-specific microdissection coupled with Protein Chip array technologies:applications in caner research[J].Biotechniques,2000,29(5):1066.
10Plebani M,Basso D,Navaglia F,et al.Clinical evaluation of seven tumor markers in lung cancer diagnosis,can any combination improve the results[J].Br J Cancer,1995,72(3):170.
